Affibody Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 65

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $21M

  • Investors
  • 4

Affibody General Information

Description

Developer of radioligand therapies designed to selectively target tumors across a broad range of cancers. The company offers Affibody molecule-based radioligand therapies and a drug discovery platform for oncology, immunology, and inflammation, enabling healthcare providers and biopharmaceutical partners to develop targeted treatments for patients with high unmet medical needs.

Contact Information

Website
www.affibody.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scheeles väg 2
  • 171 65 Solna
  • Sweden
+46 08-598
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Scheeles väg 2
  • 171 65 Solna
  • Sweden
+46 08-598

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affibody Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Debt - General 22-Dec-2022 $21M Completed Profitable
6. Secondary Transaction - Private 01-Feb-2021 Completed Profitable
5. Later Stage VC 08-Mar-2018 Completed Profitable
4. Secondary Transaction - Private 01-Jan-2014 Completed Profitable
3. Later Stage VC 30-Mar-2007 Completed Generating Revenue
2. Early Stage VC 03-Oct-2001 $28M $28M Completed Startup
1. Early Stage VC 30-Jun-2000 Completed Startup
To view Affibody’s complete valuation and funding history, request access »

Affibody Patents

Affibody Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026114946-A1 Izokibep for use in a treatment of psoriatic arthritis Pending 26-Nov-2024
AU-2025212066-A1 Her2-binding polypeptide Pending 25-Jan-2024
WO-2025158010-A1 Her2-binding polypeptide Pending 25-Jan-2024
EP-4773985-A1 Methods of treating hidradenitis suppurativa Pending 08-Sep-2023
WO-2025054498-A1 Methods of treating hidradenitis suppurativa Inactive 08-Sep-2023 A61P17/00
To view Affibody’s complete patent history, request access »

Affibody Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affibody Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Investor PE/Buyout Minority
Angel (individual) Minority
Angel (individual) Minority
KTH Ventures Venture Capital Minority
To view Affibody’s complete investors history, request access »

Affibody Acquisitions (1)

Affibody’s most recent deal was a Merger/Acquisition with Visual Bioinformatics. The deal was made on 29-Jun-2001.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Visual Bioinformatics 29-Jun-2001 Merger/Acquisition Other Healthcare Technology Systems
To view Affibody’s complete acquisitions history, request access »

Affibody FAQs

  • When was Affibody founded?

    Affibody was founded in 1998.

  • Where is Affibody headquartered?

    Affibody is headquartered in Solna, Sweden.

  • What is the size of Affibody?

    Affibody has 65 total employees.

  • What industry is Affibody in?

    Affibody’s primary industry is Drug Discovery.

  • Is Affibody a private or public company?

    Affibody is a Private company.

  • What is Affibody’s current revenue?

    The current revenue for Affibody is .

  • How much funding has Affibody raised over time?

    Affibody has raised $102M.

  • Who are Affibody’s investors?

    Investor, , , and KTH Ventures have invested in Affibody.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process